Please login to the form below

Not currently logged in
Email:
Password:

RNA interference

This page shows the latest RNA interference news and features for those working in and with pharma, biotech and healthcare.

Moderna CEO makes case for firm’s lofty valuation

Moderna CEO makes case for firm’s lofty valuation

Moderna’s specialty is in messenger RNA (mRNA) drugs which are designed to turn a patient’s own cells into drug-manufacturing factories, hijacking the cellular machinery involved in protein production. ... It’s potentially a whole new drug class,

Latest news

More from news
Approximately 1 fully matching, plus 31 partially matching documents found.

Latest appointments

  • Silence appoints chief medical officer Silence appoints chief medical officer

    These studies involve Silence's investigational portfolio of RNA interference (RNAi) therapeutics, which aim to treat conditions by selectively turning off genes expressed in an individual with a certain disease.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Just::Health Communications

Just:: is a different kind of healthcare communications agency. Since 2006, we’ve been collaborating with clients around the world to...

Latest intelligence

London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...
The Future of Pharma sales: fast forward to 2029
Change is inevitable, and necessary, for growth in business....
International Women's Day - 8 March 2019
International Women's Day has been celebrated since its inception in 1911. But how far have we come?...

Infographics